Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly A Nichol

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|January 25, 2003
Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in CanadaKimberly A Nichol, George G Zhanel, Daryl J Hoban
Antimicrobial Agents and Chemotherapy|September 18, 2002
Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniaeKimberly A Nichol, George G Zhanel, Daryl J Hoban
Diagnostic Microbiology and Infectious Disease|May 3, 2006
Native-valve bacterial endocarditis caused by Lactococcus garvieaeDonald C Vinh, Kimberly A Nichol, Fern Rand, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2002
Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claimsHeather J Smith, Kimberly A Nichol, Daryl J Hoban, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2003
Stretching the mutant prevention concentration (MPC) beyond its limitsHeather J Smith, Kimberly A Nichol, Daryl J Hoban, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Stability of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived mutantsHeather J Smith-Adam, Kimberly A Nichol, Daryl J Hoban, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002George G Zhanel, Lorraine Palatnick, Kimberly A Nichol, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Increasing genetic relatedness of ciprofloxacin-resistant Streptococcus pneumoniae isolated in Canada from 1997 to 2005Kimberly A Nichol, Heather J Adam, James A Karlowsky, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002George G Zhanel, Lorraine Palatnick, Kimberly A Nichol, et al.
International Journal of Antimicrobial Agents|April 20, 2006
Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North AmericaKimberly A Nichol, Michelle Sill, Nancy M Laing, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|January 25, 2003
Molecular epidemiology of penicillin-resistant and ciprofloxacin-resistant Streptococcus pneumoniae in CanadaKimberly A Nichol, George G Zhanel, Daryl J Hoban
Antimicrobial Agents and Chemotherapy|September 18, 2002
Penicillin-binding protein 1A, 2B, and 2X alterations in Canadian isolates of penicillin-resistant Streptococcus pneumoniaeKimberly A Nichol, George G Zhanel, Daryl J Hoban
Diagnostic Microbiology and Infectious Disease|May 3, 2006
Native-valve bacterial endocarditis caused by Lactococcus garvieaeDonald C Vinh, Kimberly A Nichol, Fern Rand, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 2002
Dual activity of fluoroquinolones against Streptococcus pneumoniae: the facts behind the claimsHeather J Smith, Kimberly A Nichol, Daryl J Hoban, et al.
The Journal of Antimicrobial Chemotherapy|April 30, 2003
Stretching the mutant prevention concentration (MPC) beyond its limitsHeather J Smith, Kimberly A Nichol, Daryl J Hoban, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2005
Stability of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived mutantsHeather J Smith-Adam, Kimberly A Nichol, Daryl J Hoban, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002George G Zhanel, Lorraine Palatnick, Kimberly A Nichol, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2008
Increasing genetic relatedness of ciprofloxacin-resistant Streptococcus pneumoniae isolated in Canada from 1997 to 2005Kimberly A Nichol, Heather J Adam, James A Karlowsky, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2003
Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002George G Zhanel, Lorraine Palatnick, Kimberly A Nichol, et al.
International Journal of Antimicrobial Agents|April 20, 2006
Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North AmericaKimberly A Nichol, Michelle Sill, Nancy M Laing, et al.
Pageof 3